News PharmAust Limited

Equities

PAA

AU000000PAA1

Delayed Australian S.E. Other stock markets 12:23:36 2024-04-26 am EDT			5-day change	1st Jan Change
0.25 ^AUD	0.00%		-12.28%	+117.39%

Apr. 23	Pharmaust CEO Resigns	MT
Apr. 10	PharmAust Obtains Approval to Commence Monepantel Extension Study	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharmaust CEO Resigns	Apr. 22	MT
PharmAust Obtains Approval to Commence Monepantel Extension Study	Apr. 09	MT
PharmAust Retracts CEO Statement from Media	Apr. 02	MT
PharmAust Submits Supporting Data to US FDA for Monepantel Orphan Drug Designation Request; Shares Down 7%	Mar. 13	MT
PharmAust Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 29	CI
PharmAust advances monepantel for motor neurone disease towards FDA approval	Feb. 28	AQ
PharmAust Gets US FDA Guidance for Motor Neuron Disease Medication	Feb. 16	MT
PharmAust Appoints Non-Executive Director	Feb. 07	MT
PharmAust Secures Ethics Approval for Phase One Motor Neuron Disease Extension Study; Shares Rise 6%	Jan. 29	MT
PharmAust to Amend Monepantel Orphan Drug Designation Request to FDA	Jan. 28	MT
PharmAust Ties Up with Berry Consultants for Upcoming Phase 2/3 Motor Neuron Disease Trial; Shares Rise 4%	Jan. 15	MT
PharmAust Secures Meeting with US FDA for Motor Neuron Disease Drug Application; Shares Jump 9%	Jan. 01	MT
PharmAust Secures Support for Phase 2/3 Clinical Trial Grant Request	Dec. 25	MT
PharmAust Secures R&D Tax Refund for Fiscal Year 2023	Dec. 20	MT
PharmAust Achieves 93% take Up on Options Offer	Dec. 15	MT
PharmAust to Raise AU$3.5 Million From Share Sale	Dec. 14	MT
PharmAust Concludes Phase One Study for Motor Neuron Disease Medication	Nov. 30	MT
Pharmaust Completes Dosing for All Cohort Four Patients in Phase One Study of Motor Neurone Disease; Shares Rise 3%	23-10-13	MT
PharmAust Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
PharmAust Limited Appoints Roger Aston as Non-Executive Chairman, Effective 1 September 2023	23-08-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PharmAust Limited

Equities

PAA

AU000000PAA1

Summary

Filters